Jennifer Jarrett's Net Worth
$13.7 Million
Who is Jennifer Jarrett?
Jennifer Jarrett has an estimated net worth of $13.7 Million. This is based on reported shares across multiple companies, which include ARENA PHARMACEUTICALS INC, Syndax Pharmaceuticals Inc, Arcus Biosciences, Inc., Surrozen, Inc./DE, Audentes Therapeutics, Inc., Radius Health, Inc., Zura Bio Ltd, and MEDIVATION, INC..
SEC CIK
Jennifer Jarrett's CIK is 0001671311
Past Insider Trading and Trends
2019 was Jennifer Jarrett's most active year for acquiring shares with 6 total transactions. Jennifer Jarrett's most active month to acquire stocks was the month of May. 2021 was Jennifer Jarrett's most active year for disposing of shares, totalling 20 transactions. Jennifer Jarrett's most active month to dispose stocks was the month of February. 2020 saw Jennifer Jarrett paying a total of $0.00 for 948,446 shares, this is the most they've acquired in one year. In 2023 Jennifer Jarrett cashed out on 114,504 shares for a total of $2,265,862.69, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARENA PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -11.22K |
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +37.63% | 3.07K |
—
|
—
| 11.22K |
Jun 11
| |||
Form 4
| +42.88% | 2.45K |
—
|
—
| 8.15K |
Jun 12
| |||
Form 4
| +87.02% | 2.65K |
—
|
—
| 5.7K |
Jun 13
| |||
Form 4
|
∞
| 3.05K |
—
|
—
| 3.05K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.63
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.42% | 17K |
—
|
—
| 65K |
Feb 7
| |||
Form 4
| +50.00% | 16K |
—
|
—
| 48K |
Feb 2
| |||
Form 4
| +100.00% | 16K |
—
|
—
| 32K |
Feb 2
| |||
Form 4
|
∞
| 16K |
—
|
—
| 16K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcus Biosciences, Inc. (RCUS) Snapshot price: $14.86
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.09% | -11.55K |
$17.55 | -$202,720.05 | 215.25K |
Scheduled
|
Mar 27
| ||
Form 4
| -5.60% | -13.45K |
$17.92 | -$240,941.04 | 226.8K |
Scheduled
|
Mar 18
| ||
Form 4
| -19.62% | -58.63K |
$20.09 | -$1,177,966.55 | 240.25K |
Scheduled
|
Feb 26 - Feb 27
| ||
Form 4
| +15.45% | 40K |
—
|
—
| 298.88K |
Jan 23
| |||
Form 4
| -7.68% | -21.52K |
$17.76 | -$382,212.96 | 258.88K |
Scheduled
|
Dec 22
| ||
Form 4
| -7.50% | -22.74K |
$17.92 | -$407,465.28 | 280.4K |
Scheduled
|
Dec 18 - Dec 19
| ||
Form 4
| -6.59% | -21.37K |
$19.99 | -$427,166.31 | 302.69K |
Sep 22
| |||
Form 4
| -3.72% | -12.51K |
$20.40 | -$255,122.40 | 324.06K |
Sep 18
| |||
Form 4
| -11.79% | -45.00K |
$20.25 | -$911,250.00 | 336.57K |
Jul 28
| |||
Form 4
| -3.16% | -12.44K |
$19.12 | -$237,795.44 | 381.57K |
Jun 22
| |||
Form 4
| -3.09% | -12.56K |
$19.35 | -$243,094.05 | 394K |
Jun 16
| |||
Form 4
| -2.10% | -8.73K |
$16.81 | -$146,734.49 | 406.22K |
Mar 16
| |||
Form 4
| -0.46% | -1.90K |
$23.53 | -$44,700.00 | 414.95K |
Scheduled
|
Jan 26 - Jan 27
| ||
Form 4
| +12.34% | 45.8K |
—
|
—
| 416.85K |
Jan 23
| |||
Form 4
| -10.04% | -16.48K |
$30.75 | -$506,821.83 | 147.61K |
Dec 16
| |||
Form 4
| -8.83% | -12.68K |
$26.28 | -$333,151.56 | 130.94K |
Sep 16
| |||
Form 4
| -9.67% | -12.70K |
$21.45 | -$272,292.80 | 118.62K |
Jun 16 - Jun 17
| |||
Form 4
| -8.32% | -9.62K |
$31.62 | -$304,089.54 | 105.98K |
Mar 16
| |||
Form 4
| +34.49% | 31.25K |
—
|
—
| 121.84K |
Mar 8
| |||
Form 4
| -27.76% | -34.82K |
$41.48 | -$1,444,369.37 | 90.59K |
Scheduled
|
Dec 20
| ||
Form 4
| -9.18% | -12.68K |
$40.12 | -$508,683.92 | 125.42K |
Dec 16 - Dec 17
| |||
Form 4
| -29.62% | -47.50K |
$35.35 | -$1,678,913.57 | 112.84K |
Scheduled
|
Sep 20 - Sep 21
| ||
Form 4
| -6.13% | -8.83K |
$23.89 | -$211,005.44 | 135.34K |
Jun 16 - Jun 17
| |||
Form 4
| -0.87% | -1.04K |
$24.91 | -$26,006.04 | 119.17K |
Jun 4
| |||
Form 4
| -6.89% | -8.66K |
$35.03 | -$303,393.96 | 116.97K |
Mar 16
| |||
Form 4
| +397.48% | 400K |
—
|
—
| 500.63K |
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
| +2.98% | 3K |
—
|
—
| 103.63K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surrozen, Inc./DE (SRZN) Snapshot price: $9.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Audentes Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||